Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

Beijing Center for Disease Prevention and Control

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04264312

Enrollment

76220

Registered

2020-02-11

Start date

2017-07-28

Completion date

2020-01-10

Last updated

2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B

Keywords

HBV, Antiviral Treatment Rate, China, Baseline Investigation

Brief summary

Through two-stage stratified cluster sampling, investigators studied the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infection-related liver disease population.

Detailed description

Hepatitis B virus (HBV) infection is a major public health problem worldwide. China has the world's largest burden of HBV infection and will be a major contributor towards the global elimination of hepatitis B disease by 2030. While, the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infections is still unknown. In response to the above situation, Sampling applied a two-stage stratified cluster sampling design in 16 Districts and 331 Townships. Investigators wanted to know the one who is eligible for treated criteria based on community in 25 and over years old in Beijing.

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

25 Years to No maximum

Healthy volunteers

Inclusion criteria

* older than 25 years old; * Residents with medical insurance coverage lived in Beijing more than 6 months .

Exclusion criteria

* Persons with pacemakers; * Pregnant women; * Persons with ascites; * The one whose wound was not cured at the right upper abdomen

Design outcomes

Primary

Measure	Time frame	Description
HBsAg positive rate	Baseline	Complete HBsAg tests for more than 60,000 people over the age of 25 in Beijing
Average rate of chronic hepatitis B accepting antiviral treatment	Baseline	The one who is eligible for HBV treated criteria based on community in 25 and over years old in Beijing.

Countries

China

Outcome results